🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Chemotherapy

A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC NCT06754644Phase 31 site📍 Jinan Qilu Pharmaceutical Co., Ltd. · Tests: QL2107, Pemetrexed, Carboplatin, Keytruda® ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site📍 Liverpool Pierian Biosciences · Tests: No intervention Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer NCT06451211Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Tislelizumab, Oxaliplatin, S-1, Capecitabine Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma NCT04448522Phase 36 sites📍 Guangzhou📍 Guangzhou📍 Shaoguan Sun Yat-sen University · Tests: reduced dosage IMRT, conventional dosage IMRT Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy NCT05800600Phase 21 site📍 Philadelphia Fox Chase Cancer Center · Tests: Venofer Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site📍 Chicago University of Chicago · Tests: Toripalimab, Carboplatin, Paclitaxel BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron NCT04150614Phase 41 site📍 Chicago University of Illinois at Chicago · Tests: Granisetron Transdermal Patch, Intravenous Dexamethasone, Ondansetron An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting NCT06749886Phase 21 site📍 Shanghai Shanghai Pulmonary Hospital, Shanghai, China · Tests: Denosumab, tislelizumab, Docetaxel The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. NCT05973851Phase 312 sites📍 Innsbruck📍 Bielefeld📍 Dortmund Dr. Inge Winter · Tests: Esketamine Nasal Product, Ketamine Hydrochloride, Esketamine hydrochloride, Second-line Antidepressants AI-Assisted Chemotherapy Side Effect Management NCT07198581NA1 site📍 Incheon Incheon St.Mary's Hospital · Tests: LLM-assisted chemotherapy side effect management Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis NCT07491536NA1 site📍 Pavia University of Pavia · Tests: Gas Ozone Therapy, Biomimetic Oral Care Regimen To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer NCT06039644NA1 site📍 Taipei GenMont Biotech Incorporation · Tests: Probiotic, Placebo Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not NCT05871099Phase 31 site📍 Qingdao The Affiliated Hospital of Qingdao University · Tests: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER NCT07178808Phase 21 site📍 Gilbert Banner Health · Tests: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC) NCT07055399Phase 21 site📍 Fuzhou Fujian Cancer Hospital · Tests: neoadjuvant chemo-immunotherapy: Iparomlimab and tuvonralimab plus cisplatin,nab-paclitaxel for 1 cycle and Iparomlimab… FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma NCT07012798Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Durvalumab, Bevacizumab, HAIC of FOLFOX Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) NCT07120698Phase 22 sites📍 Guangzhou📍 Chengdu Guangdong Association of Clinical Trials · Tests: Sintilimab Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure NCT05603104Phase 31 site📍 Ramat Gan Dr. Inge Winter · Tests: Clozapine, Esketamine Nasal Product, Escitalopram, Sertraline, Venlafaxine Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry NCT04996732n/a1 site📍 Shanghai Fudan University · Tests: hospitalization All-extremity Exercise During Breast Cancer Chemotherapy NCT04914663NA1 site📍 Gainesville University of Florida · Tests: Exercise training Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients NCT04765514Phase 22 sites📍 Calgary📍 Edmonton AHS Cancer Control Alberta · Tests: Temozolomide monotherapy, Chemo-Radiotherapy with concurrent temozolomide. DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer NCT06275958Phase 336 sites📍 's-Hertogenbosch📍 Alkmaar📍 Amstelveen Leiden University Medical Center · Tests: Doublet Chemotherapy, Standard Dose (100%), Doublet Chemotherapy, Dose-reduced (75%), Monotherapy, Standard Dose (100%)… Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy NCT07386444NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Inspiratory muscle training ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs NCT06775743Phase 21 site📍 Shanghai Fudan University · Tests: ORIENT-31 regimen, SBRT Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia NCT05827549Phase 210 sites📍 Daegu📍 Daejeon📍 Hwasun Ho Joon Im · Tests: Reinduction(4weeks), Cosolodation 1st(3weeks), Consolidation 2nd(3weeks), Blinatumomab 1st(High Risk Group)_4 Weeks, Bl… Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes. NCT04019678NA1 site📍 Rozzano Istituto Clinico Humanitas · Tests: Omission of Axillary dissection Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) NCT05872685Phase 25 sites📍 Hangzhou📍 Hangzhou📍 Lishui Yu jiren · Tests: S1, Oxaliplatin, Serplulimab, Placebo EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma NCT06802835Phase 1, Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: EGFR Antibody, PD-1 antibody, Gemcitabine, Cisplatin, IMRT Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients NCT06634199n/a22 sites📍 Ferrol📍 Alicante📍 Badalona Fundación GECP · Tests: Durvalumab Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer NCT07189455Phase 31 site📍 Shanghai Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Tests: ZG006, Topotecan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy